Cargando…
Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma
BACKGROUND: Neoantigens are considered ideal targets for immunotherapy, especially tumor vaccine, because of their strong specificity and immunogenicity. Here, we developed a neoantigen nanovaccine used liposomes with lymph-node targeting characteristic. METHODS: Our nanovaccine was composed of neoa...
Autores principales: | Chu, Yanhong, Qian, Lingyu, Ke, Yaohua, Feng, Xiaoyu, Chen, Xinjie, Liu, Fangcen, Yu, Lixia, Zhang, Lianru, Tao, Yaping, Xu, Rui, Wei, Jia, Liu, Baorui, Liu, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006542/ https://www.ncbi.nlm.nih.gov/pubmed/35418151 http://dx.doi.org/10.1186/s12951-022-01397-7 |
Ejemplares similares
-
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
por: Liu, Qin, et al.
Publicado: (2022) -
Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer (Adv. Sci. 1/2023)
por: Liu, Qin, et al.
Publicado: (2023) -
Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination
por: Chu, Yanhong, et al.
Publicado: (2021) -
Personalized cancer neoantigen vaccines come of age
por: Chu, Yanhong, et al.
Publicado: (2018) -
Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report
por: Shao, Jie, et al.
Publicado: (2022)